Children of Parents with Obesity or Overweight Face Increased Risk of MASLD Later in Life
DDW 2024. Offspring with both parents with overweight had a nearly 3-fold increased risk of MASLD in young adulthood, according to new data.
Risk of Diabetes-related Complications Higher in Men than Women: Daily Dose
Your daily dose of the clinical news you may have missed.
COVID-19 Infection in Second Trimester May Increase Risk of Preeclampsia, New Study Finds
Data presented at ACOG 2024 suggest SARS-CoV-2 infection early in pregnancy can lead to a higher likelihood of preeclampsia, as well as more severe disease.
Dupilumab in Replicate Phase 3 Trial Significantly Reduces COPD Exacerbations, Improves Lung Function, with PDUFA Date in Sight
Dupilumab reduced COPD exacerbations by 34% in adults with uncontrolled symptoms and evidence of T2 inflammation, and significantly improved lung function.
GLP-1 Agonists Reduce Risk of Cirrhosis, HCC in Adults with MASLD and T2D
DDW 24. New research shows patients with MASLD and T2D who used GLP-1 agonists had a reduced risk of progression to cirrhosis and HCC vs non-users.
Irregular Menstrual Cycle Linked to Cardiometabolic Conditions Regardless of PCOS Status: Daily Dose
Tezepelumab Cuts COPD Exacerbation Rate in High-Risk Population: COURSE Trial Highlights with Dave Singh, MD
Dave Singh, MD, lead investigator for the phase 2a COURSE trial of tezepelumab in moderate to very severe COPD, highlights the drug's promise in vulnerable groups.
Tezepelumab Reduces Rate of COPD Exacerbations in Individuals with Wide Range of Blood Eosinophil Levels: Phase 2a COURSE Trial Findings
ATS: The biologic shows promise in a range of people with COPD, particularly those with BEC levels of 150 cells/μL and greater, according to findings released at the 2024 ATS meeting.
ETHOS Post-Hoc Analysis: Dave Singh, MD, Highlights Breztri Reduction of Cardiopulmonary Risk in COPD
The triple therapy cut risk of a first cardiopulmonary event by 20% vs dual therapy in addition to significantly reducing COPD exacerbations, PI Singh told Patient Care.
New Study Shows Men with Diabetes Have Higher Risk of Disease-related Complications than Women
Men with diabetes had a greater risk of CVD, lower limb and kidney complications, and diabetic retinopathy compared to women with diabetes.
Vaping, Drinking Before Pregnancy Not Tied to Higher Risk of Miscarriage: Daily Dose
Menopausal VMS Severity, Frequency Reduced Significantly with Elinzanetant: Bayer Shares Data from Pivotal OASIS 1 and 2 Trials
The 2 phase 3 trials met all primary and secondary endpoints, showing statistically significant reduction in symptoms and sleep disturbance and improvement in quality of life.
Roche Says Investigational Once-Weekly "Twincretin" Shows Promise in Adults with Obesity in Early Stage Clinical Trial
In the phase 1b trial, treatment with once-weekly subcutaneous CT-388 led to a statistically significant mean placebo-adjusted weight loss of nearly 20%.
Cardiovascular-Kidney-Metabolic Syndrome in the US: Daily Dose
AstraZeneca’s Investigational COVID-19 Prevention Drug Reduces Risk of Infection in Immunocompromised Persons
Sipavibart met both dual primary endpoints in the SUPERNOVA phase 3 trial.
Lilly's Once-A-Week Insulin Demonstrates Safety, HbA1c Lowering Consistent with Daily Insulin
Safety and HbA1c reduction with efsitora alfa dosed once weekly was comparable to both daily insulin degludec and daily insulin glargine, announced Lilly.
Irregular Menstrual Cycle Associated with Cardiometabolic Conditions in Women Regardless of PCOS Status
New research shows that menstrual irregularity is associated with a higher prevalence of cardiometabolic conditions in women, even in the absence of PCOS.
HRSA Women's Preventive Health Services Guidelines: A Topline Look
Get a quick overview of recommendations for preventive health services and screenings focused on the unique needs of women across the lifespan.
SGLT2i Use and Improved QoL, Functional Capacity in Adults With HF: Daily Dose
Teal Health Granted Breakthrough Device Designation for Self-Collect Cervical Cancer Screening Device
